The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pantoprazole Teva Pharma 40 mg gastro-resistant tablets

Teva Pharma B.V.PA0749/144/002

Main Information

Trade NamePantoprazole Teva Pharma 40 mg gastro-resistant tablets
Active SubstancesPantoprazole sodium sesquihydrate
Dosage FormGastro-resistant tablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/144/002

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC02 pantoprazole


License statusAuthorised
Licence Issued17/12/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0013-004-005
Interchangeable List DocumentPDF of Interchangeable List
« Back